Premium
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma ( GEN 503): final results of an open‐label, phase 1/2 study
Author(s) -
Plesner Torben,
Arkenau HendrikTobias,
Gay Francesca,
Minnema Monique C.,
Boccadoro Mario,
Moreau Philippe,
Cavenagh Jamie,
Perrot Aurore,
Laubach Jacob P.,
Krejcik Jakub,
Ahmadi Tahamtan,
Boer Carla,
Chen Diana,
Chiu Christopher,
Schecter Jordan M.,
Richardson Paul G.
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15879
Subject(s) - lenalidomide , daratumumab , tolerability , medicine , dexamethasone , refractory (planetary science) , oncology , multiple myeloma , open label , pharmacology , clinical trial , adverse effect , physics , astrobiology
nal of Medicine, 371, 2477–2487. Gibson, C.J., Lindsley, R.C., Tchekmedyian, V., Mar, B.G., Shi, J., Jaiswal, S., Bosworth, A., Francisco, L., He, J., Bansal, A., Morgan, E.A., Lacasce, A.S., Freedman, A.S., Fisher, D.C., Jacobsen, E., Armand, P., Alyea, E.P., Koreth, J., Ho, V., Soiffer, R.J., Antin, J.H., Ritz, J., Nikiforow, S., Forman, S.J., Michor, F., Neuberg, D., Bhatia, R., Bhatia, S. & Ebert, B.L. (2017) Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. Journal of Clinical Oncology, 35, 1598–1605. Gillis, N.K., Ball, M., Zhang, Q., Ma, Z., Zhao, Y., Yoder, S.J., Balasis, M.E., Mesa, T.E., Sallman, D.A., Lancet, J.E., Komrokji, R.S., List, A.F., McLeod, H.L., Alsina, M., Baz, R., Shain, K.H., Rollison, D.E. & Padron, E. (2017) Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. The Lancet Oncology, 18, 112–121. Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P.V., Mar, B.G., Lindsley, R.C., Mermel, C.H., Burtt, N., Chavez, A., Higgins, J.M., Moltchanov, V., Kuo, F.C., Kluk, M.J., Henderson, B., Kinnunen, L., Koistinen, H.A., Ladenvall, C., Getz, G., Correa, A., Banahan, B.F., Gabriel, S., Kathiresan, S., Stringham, H.M., McCarthy, M.I., Boehnke, M., Tuomilehto, J., Haiman, C., Groop, L., Atzmon, G., Wilson, J.G., Neuberg, D., Altshuler, D. & Ebert, B.L. (2014) Age-related clonal hematopoiesis associated with adverse outcomes. New England Journal of Medicine, 371, 2488– 2498. Kluk, M.J., Lindsley, R.C., Aster, J.C., Lindeman, N.I., Szeto, D., Hall, D. & Kuo, F.C. (2016) Validation and implementation of a custom nextgeneration sequencing clinical assay for hematologic malignancies. The Journal of Molecular Diagnostics, 18, 507–515. Severson, E.A., Riedlinger, G.M., Connelly, C.F., Vergilio, J.A., Goldfinger, M., Ramkissoon, S., Frampton, G.M., Ross, J.S., Fratella-Calabrese, A., Gay, L., Ali, S., Miller, V., Elvin, J., Hadigol, M., Hirshfield, K.M., RodriguezRodriguez, L., Ganesan, S. & Khiabanian, H. (2018) Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens. Blood, 131, 2501– 2505. Takahashi, K., Wang, F., Kantarjian, H., Doss, D., Khanna, K., Thompson, E., Zhao, L., Patel, K., Neelapu, S., Gumbs, C., Bueso-Ramos, C., DiNardo, C.D., Colla, S., Ravandi, F., Zhang, J., Huang, X., Wu, X., Samaniego, F., Garcia-Manero, G. & Futreal, P.A. (2017) Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study. The Lancet Oncology, 18, 100–111. Xie, M., Lu, C., Wang, J., McLellan, M.D., Johnson, K.J., Wendl, M.C., McMichael, J.F., Schmidt, H.K., Yellapantula, V., Miller, C.A., Ozenberger, B.A., Welch, J.S., Link, D.C., Walter, M.J., Mardis, E.R., Dipersio, J.F., Chen, F., Wilson, R.K., Ley, T.J. & Ding, L. (2014) Agerelated mutations associated with clonal hematopoietic expansion and malignancies. Nature Medicine, 20, 1472–1478. Young, A.L., Challen, G.A., Birmann, B.M. & Druley, T.E. (2016) Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nature Communications, 7, 12484.